Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Cells Expressing Alpha Fetoprotein (Alpha 1 Fetoprotein or Alpha Fetoglobulin or AFP) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Alpha Fetoprotein (Alpha 1 Fetoprotein or Alpha Fetoglobulin or AFP) - Drugs in Development, 2021 SUMMARY Cells Expressing Alpha Fetoprotein (Alpha 1 Fetoprotein or Alpha Fetoglobulin...

April 2021 35 pages

Cells Expressing Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Drugs in Development, 2021 SUM...

April 2021 85 pages

Cells Expressing CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs in Development, 2021 SUMMARY Cells Expressing CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimul...

April 2021 60 pages

Cells Expressing CD3 - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing CD3 - Drugs in Development, 2021 SUMMARY Cells Expressing CD3 - Drugs in Development, 2021 provides in depth analysis on Cells Expressing CD3 targeted pipeline therapeutics. The repor...

April 2021 35 pages

Cells Expressing CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteoglycan or Hermes Antigen or Hyaluronate Receptor or Phagocytic Glycoprotein 1 or CD44) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteoglycan or Hermes Antigen or Hyaluron...

April 2021 35 pages

Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necrosis Factor Ligand Superfamily Member 7 or CD70) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necrosis Factor Ligand Superfamily Member 7 or CD70) - Drugs in Development, 2021 SUMMARY Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necros...

April 2021 35 pages

Cells Expressing Claudin 18 (CLDN18) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Claudin 18 (CLDN18) - Drugs in Development, 2021 SUMMARY Cells Expressing Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Cells Expressing Claudin 18 (C...

April 2021 60 pages

Cells Expressing Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021 SUMMARY Cells Expressing Cytotoxic T Lymphocyte Protein 4...

April 2021 30 pages

Cells Expressing Delta Like Protein 3 (Drosophila Delta Homolog 3 or DLL3) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Delta Like Protein 3 (Drosophila Delta Homolog 3 or DLL3) - Drugs in Development, 2021 SUMMARY Cells Expressing Delta Like Protein 3 (Drosophila Delta Homolog 3 or DLL3) - Drugs in De...

April 2021 35 pages

Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021 SUMMARY Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021 provides in depth analysis on Cells Expressing Folate...

April 2021 30 pages

Cells Expressing Glypican 3 (Heparan Sulphate Proteoglycan or Intestinal Protein OCI 5 or GTR2 2 or MXR7 or GPC3) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Glypican 3 (Heparan Sulphate Proteoglycan or Intestinal Protein OCI 5 or GTR2 2 or MXR7 or GPC3) - Drugs in Development, 2021 SUMMARY Cells Expressing Glypican 3 (Heparan Sulphate Pro...

April 2021 80 pages

Cells Expressing GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021 SUMMARY Cells Expressing GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) -...

April 2021 35 pages

Cells Expressing Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) - Drugs in Development, 202...

April 2021 35 pages

Cells Expressing Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 SUMMARY Cells Expressing Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 provides in depth analysis...

April 2021 30 pages

Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC...

April 2021 30 pages

Cells Expressing Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 SUMMARY Cells Expressing Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD...

April 2021 35 pages

Cells Expressing Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Drugs in Development, 2021 SUMMARY Cells Expressing Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD...

April 2021 30 pages

Cells Expressing Interleukin 13 Receptor Subunit Alpha 2 (Interleukin 13 Binding Protein or CD213a2 or IL13RA2) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Interleukin 13 Receptor Subunit Alpha 2 (Interleukin 13 Binding Protein or CD213a2 or IL13RA2) - Drugs in Development, 2021 SUMMARY Cells Expressing Interleukin 13 Receptor Subunit Al...

April 2021 45 pages

Cells Expressing Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in Development, 2021 SUMMARY Cells Expressing Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p...

April 2021 35 pages

Cells Expressing Interleukin 3 Receptor Subunit Alpha (CD123 or IL3RA) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Interleukin 3 Receptor Subunit Alpha (CD123 or IL3RA) - Drugs in Development, 2021 SUMMARY Cells Expressing Interleukin 3 Receptor Subunit Alpha (CD123 or IL3RA) - Drugs in Developmen...

April 2021 85 pages

Cells Expressing Latent Membrane Protein 1 (Protein p63 or LMP1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Latent Membrane Protein 1 (Protein p63 or LMP1) - Drugs in Development, 2021 SUMMARY Cells Expressing Latent Membrane Protein 1 (Protein p63 or LMP1) - Drugs in Development, 2021 prov...

April 2021 35 pages

Cells Expressing Latent Membrane Protein 2 (Terminal Protein or LMP2) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Latent Membrane Protein 2 (Terminal Protein or LMP2) - Drugs in Development, 2021 SUMMARY Cells Expressing Latent Membrane Protein 2 (Terminal Protein or LMP2) - Drugs in Development,...

April 2021 35 pages

Cells Expressing Leukocyte Antigen CD37 (Tetraspanin 26 or CD37) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Leukocyte Antigen CD37 (Tetraspanin 26 or CD37) - Drugs in Development, 2021 SUMMARY Cells Expressing Leukocyte Antigen CD37 (Tetraspanin 26 or CD37) - Drugs in Development, 2021 prov...

April 2021 35 pages

Cells Expressing Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or p145 c Kit or CD117 or KIT or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protei...

April 2021 35 pages

Cells Expressing Melanoma Antigen Preferentially Expressed In Tumors (Cancer/Testis Antigen 130 or Opa Interacting Protein 4 or OIP4 or Preferentially Expressed Antigen Of Melanoma or PRAME) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Melanoma Antigen Preferentially Expressed In Tumors (Cancer/Testis Antigen 130 or Opa Interacting Protein 4 or OIP4 or Preferentially Expressed Antigen Of Melanoma or PRAME) - Drugs i...

April 2021 35 pages

Cells Expressing Melanoma Antigen Recognized By T Cells 1 (Protein Melan A or Antigen SK29 AA or Antigen LB39 AA or MART1 or MLANA) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Melanoma Antigen Recognized By T Cells 1 (Protein Melan A or Antigen SK29 AA or Antigen LB39 AA or MART1 or MLANA) - Drugs in Development, 2021 SUMMARY Cells Expressing Melanoma Antig...

April 2021 30 pages

Cells Expressing Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021 SUMMARY Cells Expressing Melanoma Associated Antigen...

April 2021 35 pages

Cells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) - Drugs in Development, 2021 SUMMARY Cells Expressing Melan...

April 2021 45 pages

Cells Expressing Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021 SUMMARY Cells Expressing Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte...

April 2021 110 pages

Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021 SUMMARY Cells Expressing Mucin 16 (Ovarian Cancer Related...

April 2021 35 pages

Cells Expressing Myeloid Cell Surface Antigen CD33 (Sialic Acid Binding Ig Like Lectin 3 or gp67 or CD33) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Myeloid Cell Surface Antigen CD33 (Sialic Acid Binding Ig Like Lectin 3 or gp67 or CD33) - Drugs in Development, 2021 SUMMARY Cells Expressing Myeloid Cell Surface Antigen CD33 (Siali...

April 2021 90 pages

Cells Expressing Neural Cell Adhesion Molecule 1 (Antigen Recognized By Monoclonal Antibody 5.1H11 or CD56 or NCAM1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Neural Cell Adhesion Molecule 1 (Antigen Recognized By Monoclonal Antibody 5.1H11 or CD56 or NCAM1) - Drugs in Development, 2021 SUMMARY Cells Expressing Neural Cell Adhesion Molecule...

April 2021 35 pages

Cells Expressing Neural Cell Adhesion Molecule L1 (CD171 or L1CAM) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Neural Cell Adhesion Molecule L1 (CD171 or L1CAM) - Drugs in Development, 2021 SUMMARY Cells Expressing Neural Cell Adhesion Molecule L1 (CD171 or L1CAM) - Drugs in Development, 2021...

April 2021 30 pages

Cells Expressing Phosphatidylserine - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Phosphatidylserine - Drugs in Development, 2021 SUMMARY Cells Expressing Phosphatidylserine - Drugs in Development, 2021 provides in depth analysis on Cells Expressing Phosphatidylser...

April 2021 35 pages

Cells Expressing Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021 SUMMARY Cells Expressing Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD27...

April 2021 55 pages

Cells Expressing Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Development, 2021 SUMMARY Cells Expressing Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Develo...

April 2021 40 pages

Cells Expressing Prominin 1 (Antigen AC133 or Prominin Like Protein 1 or CD133 or PROM1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Prominin 1 (Antigen AC133 or Prominin Like Protein 1 or CD133 or PROM1) - Drugs in Development, 2021 SUMMARY Cells Expressing Prominin 1 (Antigen AC133 or Prominin Like Protein 1 or C...

April 2021 35 pages

Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs in Development, 2021 SUMMARY Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs in Development, 2021 provides in depth analysis on Ce...

April 2021 35 pages

Cells Expressing Somatostatin Receptor (SSTR) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Somatostatin Receptor (SSTR) - Drugs in Development, 2021 SUMMARY Cells Expressing Somatostatin Receptor (SSTR) - Drugs in Development, 2021 provides in depth analysis on Cells Expres...

April 2021 30 pages

Cells Expressing Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021 SUMMARY Cells Expressing Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021 provides...

April 2021 35 pages

Cells Expressing Syndecan 1 (CD138 or SDC1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Syndecan 1 (CD138 or SDC1) - Drugs in Development, 2021 SUMMARY Cells Expressing Syndecan 1 (CD138 or SDC1) - Drugs in Development, 2021 provides in depth analysis on Cells Expressing...

April 2021 40 pages

Cells Expressing T Cell Antigen CD7 (GP40 or T Cell Leukemia Antigen or T Cell Surface Antigen Leu 9 or TP41 or CD7) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing T Cell Antigen CD7 (GP40 or T Cell Leukemia Antigen or T Cell Surface Antigen Leu 9 or TP41 or CD7) - Drugs in Development, 2021 SUMMARY Cells Expressing T Cell Antigen CD7 (GP40 or T...

April 2021 45 pages

Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 SUMMARY Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen...

April 2021 30 pages

Cells Expressing T Cell Surface Glycoprotein CD5 (Lymphocyte Antigen T1/Leu 1 or CD5) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing T Cell Surface Glycoprotein CD5 (Lymphocyte Antigen T1/Leu 1 or CD5) - Drugs in Development, 2021 SUMMARY Cells Expressing T Cell Surface Glycoprotein CD5 (Lymphocyte Antigen T1/Leu 1...

April 2021 35 pages

Cells Expressing Tumor Associated Glycoprotein 72 (TAG72) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Tumor Associated Glycoprotein 72 (TAG72) - Drugs in Development, 2021 SUMMARY Cells Expressing Tumor Associated Glycoprotein 72 (TAG72) - Drugs in Development, 2021 provides in depth...

April 2021 30 pages

Cells Expressing Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Cells Expressing Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or A...

April 2021 30 pages

Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021 SUMMARY Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021 provides in depth analysis on Ce...

April 2021 65 pages

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Drugs in Development, 2021

US$ 3,000.00

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Drugs in Development, 2021 SUMMARY Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprot...

April 2021 70 pages

Cellulitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Cellulitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Cellulitis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Cellulitis pipeline landscape. The report...

April 2021 30 pages

Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Central Nerv...

April 2021 35 pages

Filters

Clear all